What needle length and gauge should be used to infiltrate lidocaine for Nexplanon insertion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Needle Specifications for Lidocaine Infiltration During Nexplanon Insertion

Use a 25-27 gauge needle with standard length (1-1.5 inches) to infiltrate 2 mL of 1% lidocaine just under the skin along the insertion site for Nexplanon placement.

Recommended Needle Parameters

The FDA-approved Nexplanon labeling specifically recommends 2 mL of 1% lidocaine applied just under the skin along the insertion canal 1. While the label does not specify exact needle gauge, dermatologic surgery guidelines and clinical practice provide clear direction:

Gauge Selection

  • 25-27 gauge needles are optimal for subcutaneous lidocaine infiltration 2
  • Thinner needles (27-30 gauge) reduce injection pain compared to thicker needles 3, 4, 5
  • However, 27 gauge provides better tissue penetration and structural integrity than 30 gauge for subcutaneous work 6
  • 27 gauge strikes the best balance between patient comfort and practical handling for arm infiltration

Length Considerations

  • Standard 1-1.5 inch needle length is appropriate for subcutaneous infiltration in the arm
  • The Nexplanon insertion site is subdermal (just under the skin), not requiring deep penetration 1
  • Longer needles (1.5 inches) are used for deeper blocks like paracervical blocks (22-25 gauge, 1.5") 7, but Nexplanon requires only superficial infiltration

Clinical Technique

Infiltration approach:

  • Inject 2 mL of 1% lidocaine subdermally along the planned 4 cm insertion tract
  • The insertion site is 8-10 cm from the medial epicondyle of the humerus, 3-5 cm posterior to the biceps-triceps sulcus 1
  • Aspirate before injection to avoid intravascular administration 2
  • Use slow, incremental injection technique to minimize discomfort

Pain Reduction Strategies

Evidence supports several techniques to reduce injection discomfort:

  • Smaller gauge needles (27-30 gauge) significantly reduce pain during lidocaine injection 3, 5, 8
  • Buffering lidocaine with sodium bicarbonate (4 mL lidocaine + 1 mL bicarbonate) reduces burning sensation 7, 5
  • The 30-gauge needle with buffered lidocaine produced lowest pain scores in controlled studies 5

Critical Safety Points

Avoid these common pitfalls:

  • Do not use needles larger than 25 gauge for initial infiltration—they cause unnecessary pain 4, 5
  • Never exceed maximum lidocaine doses: 4.5 mg/kg without epinephrine or 7.0 mg/kg with epinephrine in adults 2
  • For 2 mL of 1% lidocaine (20 mg total), toxicity risk is negligible in adults
  • Always palpate the implant immediately after insertion to confirm proper subdermal placement 1

Deep insertion complications: If lidocaine is infiltrated too deeply or the implant is placed intramuscularly/intrafascially, serious complications including nerve injury, vascular injury, and implant migration (even to pulmonary vasculature) can occur 1, 9, 10. The anesthetic should be placed subdermally, not deep to fascia.

References

Guideline

guidelines for the use of local anesthesia in office-based dermatologic surgery.

Journal of the American Academy of Dermatology, 2016

Research

Finer Needles Reduce Pain Associated With Injection of Local Anesthetic Using a Minimal Insertion Injection Technique.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018

Research

The importance of needle gauge for pain during injection of lidocaine.

Journal of plastic surgery and hand surgery, 2016

Guideline

best practices for reducing pain associated with intrauterine device placement.

American Journal of Obstetrics and Gynecology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.